Orthopedic Biomaterials Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 24.50 Bn

Forecast Year, 2035

USD 49.14 Bn

CAGR, 2026 - 2035

7.21%

Report Coverage

Global

What is the Orthopedic Biomaterials Market Size?

The global orthopedic biomaterials market size accounted for USD 24.50 billion in 2025 and is anticipated to reach around USD 49.14 billion by 2035, growing at a CAGR of 7.21% from 2026 to 2035. Increasing demand for orthopedic implants and rising injuries owing to sports and road calamities fuel the growth of the global orthopedic biomaterials market.

Orthopedic Biomaterials Market Key Takeaways

• North America dominated the global market with the highest market share of 37% in 2025.
• Asia-Pacific is expected to expand at the largest CAGR between 2026 and 2035.
• By Material, the ceramics & bioactive glass segment dominated the market in 2025.
• By Application, the orthopedic implant segment dominated the global orthopedic biomaterials market in 2025.

Orthopedic Biomaterials Market Growth Factors

• The orthopedic biomaterials market is growing due to the rising number of patients on account of the growing number of the geriatric population, increasing surgeries and growing health awareness among the young generation.
• Rapidly increasing demand for next generation biomaterial products, which are customized to meet the requirements of orthopedic procedures, will further strengthen the growth of the market worldwide.
• Rise in adoption of technologically advanced products and growth of R&D activities are boosting the capabilities of orthopedic biomaterials, which further drive demand in the market.
• Increasing health awareness and the presence of new treatment methods in the region drive the growth of the orthopedic biomaterials market
• The emergence of advanced technology, such as biomaterials customised to be used in 3D printing techniques, may further offer alluring growth prospects for the market in the near future.
  Rapidly increasing trauma incidences caused by falls, sports and accidents have pushed demand for orthopedic biomaterials.

Market Scope

Segmental Analysis

Material Insights

Why has the Ceramics & Bioactive Glass Segment dominated the Orthopedic Biomaterials Market?

The ceramics & bioactive glass segment held a dominant position in the orthopedic biomaterials market in 2025, as ceramics are widely adopted in the repair of hard tissues in multiple procedures. These materials have excellent biocompatibility, high compressive strength, and the ability to support bone regeneration. These are widely used in bone graft substitutes, coating for orthopedic implants, and spinal fusion procedures.

The polymer segment is expected to grow at the fastest CAGR during the studied period in the orthopedic biomaterials market, owing to the increasing use of polymer in bone cement as well as load-bearing areas for entire joint arthroplasties. These polymers are used in a wide range of applications such as diagnostic support, drug delivery systems and useful material for tissue engineering. Ongoing advancements in polymers are enhancing their mechanical strengths, durability and compatibility with surrounding bone and soft tissues.

Application Insights

What made the orthopedic implant Segment Lead the Orthopedic Biomaterials Market?

The orthopedic implant segment registered its dominance over the global orthopedic biomaterials market in 2025, driven by increasing demand for hip, knee, shoulder, and spinal replacement procedures. Biomaterials are selected based on their strength, corrosion resistance and biocompatibility. According to the American Society of Plastic Surgeons, biomaterials are widely used for plastic surgeries, and the increasing demand for plastic surgeries across the globe is further escalating the biomaterials market.

The Orthobiologics segment is expected to witness the fastest growth in the orthopedic biomaterials market with a CAGR over the forecast period. The segment is growing due to the increasing adoption of biomaterials to accelerate bone healing and tissue generation. Biomaterials used for bone graft substitutes and regenerative therapies. Growing preference for minimally invasive treatments is encouraging wider use of orthobiologics.

End-use Insights

Why the Hospitals Segment Dominates the Orthopedic Biomaterials Market?

The hospitals segment dominated the orthopedic biomaterials market in 2025, because it is a primary centre for surgical treatments and they perform the majority of complex orthopedic surgeries, including joint replacements and trauma repair. The hospital has skilled and experienced orthopedic specialists and easy access to advanced surgical facilities, which encourages the high adoption of biomaterials procedures.

The Orthopedic Clinics segment is expected to experience the fastest growth in the orthopedic biomaterials market during the forecast period. These clinics provide focused diagnosis, treatment, and follow up services for musculoskeletal conditions. It also reduces the waiting times and offers personalised patient management. Rising patient preference for cost effective and convenient treatment options continues to support the growth of the segment.

Regional Insights

What Factors Made the North America Region the Dominant Region in the Market?

North America dominated the orthopedic biomaterials market in 2025, driven by its advanced healthcare infrastructure, high volume of joint replacement procedures, and strong adoption of innovative implant materials. The growth is further attributed to the increasing prevalence of various orthopedic surgeries. The growing number of patients requiring knee reconstruction or replacement and other orthopedic procedures is likely to enhance the growth of the market in the region.

U.S. Orthopedic Biomaterials Market Size and Growth 2026 to 2035

The U.S. orthopedic biomaterials market size was exhibited at USD 6.36 billion in 2025 and is projected to be worth around USD 13.32 billion by 2035, growing at a CAGR of 7.67% from 2026 to 2035.

U.S. Market Trends

The United States represents the largest share of the orthopedic biomaterials market in North America. The growth is driven by rising demands for knee, spine, hip, and trauma surgeries. The ongoing innovation in biomaterials, such as more durable and compatible materials, and advancements in minimally invasive techniques, encourage the adoption of orthopedic biomaterials. The country also benefits from strong investments in medical research, fast regulatory approval for new technologies and the presence of major orthopedic device manufacturers drives the market growth.

Which Factors Influence the Fastest Growth of the Asia Pacific Market?

Asia Pacific is expected to grow at the fastest CAGR in the orthopedic biomaterials market during the forecast period. The growth is driven by increased bone degeneration and disorders in developing nations such as India and China. India and China show robust growth on account of increasing population and a subsequent rise in patient population. The government initiatives and growing awareness of advanced treatment options continue to accelerate the adoption of orthopedic biomaterials. Growing expenditure on healthcare and health infrastructure will further propel the growth of the orthopedic biomaterials market in the region.

China Market Trends

China accounts for the largest share of the orthopedic biomaterials market in Asia-Pacific in 2025. The growth is driven by an increasing number of orthopedic procedures. The rising incidence of age related bone disorders and traumatic injuries has driven demand for advanced biomaterials used in implants and bone repair. The growing investment in biomedical research further strengthens the market expansion in China.

Which Factors Made Europe a Significantly Growing Region in the Market?

Europe is expected to grow at a considerable CAGR in the orthopedic biomaterials market in the coming period. The growth is supported by an ageing population, rising research activities and the availability of innovative treatments. The government in the region is focusing on improving healthcare infrastructure, which also contributes to the market expansion. Increasing research collaborations and strict quality standards are strengthening the regional market and encouraging innovation in biomaterial development.

Germany Market Trends

Germany leads the European orthopedic biomaterials market in 2025 due to its advanced medical technology industry and highly developed healthcare infrastructure. The country has highly qualified experts and high healthcare spending, which demands high quality implant materials. The supportive reimbursement policies and strategic partnerships in the healthcare sector further enhance Germany's market expansion. Strong research capabilities and continuous investment in innovative biomaterials contribute to sustained market growth.

What are the Advancements in the Market in Latin America?

Latin America held a considerable share of the orthopedic biomaterials market in 2025, supported by improving healthcare systems and access to orthopedic procedures. The rising cases of fractures, osteoarthritis, rheumatoid arthritis and sports related injuries continue to drive demand for implant materials. The rising public and private healthcare investment in the region encourages hospitals to adopt high quality biomaterials that improve implant durability and meet patients' needs.

Brazil Market Trends

Brazil accounts for the largest share of the Latin American orthopedic biomaterials market in 2025, due to increasing demand for orthopedic surgeries. An ageing population, rising trauma cases, and increased access to specilaized orthodpedic care drive the market expansion. The rising rate of obesity and sedentary lifestyle resulted in a higher occurrence of orthopedic surgeries such as joint replacement and spinal operations. The growing acceptance of advanced implant technologies continues to strengthen demand for high performance biomaterials used in orthopedic procedures.

What are the Key Trends in the Market in the Middle East and Africa Region?

The Middle East & Africa held a notable share of the orthopedic biomaterials market in 2025, with limited access to medical treatments, resulting in less development in the Middle East and Africa. Nonetheless, a gradual upsurge in spending for the development of health care centers UAE (United Arab Emirates) may contribute to the growth in the Middle East in the years to come. Governments across several countries are strengthening healthcare systems, and private hospitals are also adopting modern surgical technologies, supporting the gradual growth of orthopedic biomaterials in the Middle East & Africa region.

Saudi Arabia Market Trends

Saudi Arabia represents the leading market within the Middle East and Africa orthopedic biomaterials market in 2025, supported by substantial healthcare investments and expanding access to specialized orthopedic care. The government in the country is promoting healthcare modernization initiatives, advanced hospital facilities, which are supporting the orthodpedic biomaterials market expansion.

Competitive Landscape

The orthopedic biomaterials market is highly competitive, with global medical device manufacturers and specialized biomaterial companies focusing on innovation, clinical performance, and product quality. The leading companies in the market include Acumed LLC, Medtronic plc, Globus Medical, Inc, Johnson & Johnson, Zimmer Biomet and Wright Medical Group, Inc. Strategic acquisitions, research collaborations with research institutions and universities and partnerships with hospitals are helping to strengthen the product portfolio and expand market reach.

To achieve sustained growth in the orthopedic biomaterials market, companies should focus on developing next generation biomaterials with better compatibility and investing in 3D printing and personalised implants.

Orthopedic Biomaterials Market Companies

• Acumed, LLC
• Medtronic plc
• Globus Medical, Inc.
• Stryker Corporation
• Koninklijke DSM N.V.
• Exactech, Inc.
• Johnson & Johnson
• Zimmer Biomet
• Wright Medical Group, Inc.
• NuVasive, Inc.

Segments Covered in the Report

By Material

• Polymers
• Ceramics & Bioactive Glasses
• Calcium Phosphate Cement
• Composites
• Metal

By Application Outlook

• Orthobiologics
• Orthopedic Implants
• Viscosupplementation
• Joint Replacement
• Bio-resorbable Tissue Fixation

By End User

• Hospitals
• Orthopedic Clinics
• Others

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa